Patient Reported Outcomes in Pulmonary Arterial Hypertension

Patient Reported Outcomes in Pulmonary Arterial Hypertension

Develop a brief, new, patient reported outcome instrument that is valid for use in clinical practice and clinical trials.

This study will use the Clinical Impact Method to develop a patient reported outcome for use in patients with pulmonary arterial hypertension Clinical personnel at the study sites will approach and discuss possible participation in Phase I and II of the study with subjects from the existing pool of patients currently receiving usual and customary care at the site.

Inclusion Criteria:

• Evidence of a personally signed and dated informed consent
• Subjects aged >=18 who have documented PAH
• Speak English
• Subjects who provide written informed consent to participate in the study before being screened for the study.

Exclusion Criteria:

• Patients with non-PAH Pulmonary Hypertension
• Physical inability to complete the interview process
• Subjects who are currently enrolled in an experimental drug study